JP2020502545A5 - - Google Patents

Download PDF

Info

Publication number
JP2020502545A5
JP2020502545A5 JP2019553597A JP2019553597A JP2020502545A5 JP 2020502545 A5 JP2020502545 A5 JP 2020502545A5 JP 2019553597 A JP2019553597 A JP 2019553597A JP 2019553597 A JP2019553597 A JP 2019553597A JP 2020502545 A5 JP2020502545 A5 JP 2020502545A5
Authority
JP
Japan
Prior art keywords
proteins
level
red blood
blood cell
blood sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019553597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020502545A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2017/000282 external-priority patent/WO2018112500A1/en
Publication of JP2020502545A publication Critical patent/JP2020502545A/ja
Publication of JP2020502545A5 publication Critical patent/JP2020502545A5/ja
Priority to JP2023005614A priority Critical patent/JP7425903B2/ja
Pending legal-status Critical Current

Links

JP2019553597A 2016-12-20 2017-12-18 プロテアーゼインヒビターを用いる血液プロファイリング Pending JP2020502545A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023005614A JP7425903B2 (ja) 2016-12-20 2023-01-18 プロテアーゼインヒビターを用いる血液プロファイリング

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662436875P 2016-12-20 2016-12-20
US62/436,875 2016-12-20
US201762482582P 2017-04-06 2017-04-06
US62/482,582 2017-04-06
US201762523489P 2017-06-22 2017-06-22
US62/523,489 2017-06-22
PCT/AU2017/000282 WO2018112500A1 (en) 2016-12-20 2017-12-18 Blood profiling with protease inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023005614A Division JP7425903B2 (ja) 2016-12-20 2023-01-18 プロテアーゼインヒビターを用いる血液プロファイリング

Publications (2)

Publication Number Publication Date
JP2020502545A JP2020502545A (ja) 2020-01-23
JP2020502545A5 true JP2020502545A5 (cg-RX-API-DMAC7.html) 2021-02-18

Family

ID=62624059

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019553597A Pending JP2020502545A (ja) 2016-12-20 2017-12-18 プロテアーゼインヒビターを用いる血液プロファイリング
JP2023005614A Active JP7425903B2 (ja) 2016-12-20 2023-01-18 プロテアーゼインヒビターを用いる血液プロファイリング

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023005614A Active JP7425903B2 (ja) 2016-12-20 2023-01-18 プロテアーゼインヒビターを用いる血液プロファイリング

Country Status (7)

Country Link
US (1) US11693006B2 (cg-RX-API-DMAC7.html)
EP (1) EP3559253A4 (cg-RX-API-DMAC7.html)
JP (2) JP2020502545A (cg-RX-API-DMAC7.html)
CN (1) CN110366597B (cg-RX-API-DMAC7.html)
AU (1) AU2017379367B2 (cg-RX-API-DMAC7.html)
CA (1) CA3047607A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018112500A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1258470A1 (zh) 2015-10-07 2019-11-15 善威生物私人有限公司 血液制备和图谱分析
AU2016374643B2 (en) 2015-12-22 2023-12-14 Sangui Bio Pty. Ltd Therapeutic methods using erythrocytes
JP2020502545A (ja) 2016-12-20 2020-01-23 サングイ バイオ ピーティーワイ. エルティーディー プロテアーゼインヒビターを用いる血液プロファイリング
CN111999503B (zh) * 2020-05-28 2022-05-20 首都医科大学附属北京地坛医院 一组用于预测急性病毒性呼吸道传染病重症化的标志物及其应用和试剂盒
US11905249B2 (en) 2021-01-25 2024-02-20 Jackson State University Covalent inhibitors of equine encephalitis virus
US20230358759A1 (en) * 2022-05-04 2023-11-09 Creative Medical Technologies, Inc. Cytokine based assessment of recipient ability to respond to stem cell therapy for cartilage regeneration

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931276A (en) 1987-10-30 1990-06-05 Franco Robert S Method for introducing desired agents into red blood cells
US5858358A (en) 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
WO1992005801A1 (en) 1990-10-04 1992-04-16 University Of Virginia Alumni Patents Foundation Primate erythrocyte bound monoclonal antibody heteropolymers
FR2778851B1 (fr) 1998-05-19 2002-07-26 Aetsrn Composition a base d'inhibiteurs de cysteine-proteases pour retarder la senescence, l'autodestruction et l'hemolyse des erythrocytes
US8431117B2 (en) 1999-08-30 2013-04-30 David S Terman Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects
EP1355656A2 (en) 2000-07-24 2003-10-29 Gendel Limited Red blood cell as vehicle for agent-membrane translocation sequence conjugate
ES2498369T3 (es) 2002-04-16 2014-09-24 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Un marcador para medir cirrosis hepática
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
GB0325483D0 (en) 2003-10-31 2003-12-03 Plasmacute As Assay
AU2004286307A1 (en) * 2003-10-31 2005-05-12 Vitatex, Inc. Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US7378054B2 (en) 2004-04-16 2008-05-27 Savvipharm Inc Specimen collecting, processing and analytical assembly
EP1839056B1 (en) * 2004-12-21 2011-08-03 Yale University Diagnosis of preeclampsia
US20060166223A1 (en) 2005-01-26 2006-07-27 Reed Michael W DNA purification and analysis on nanoengineered surfaces
WO2006123253A2 (en) 2005-03-29 2006-11-23 Inverness Medical Switzerland Gmbh Device and method of monitoring a patient
US20100184049A1 (en) * 2007-04-27 2010-07-22 Steve Goodison Glycoprotein Profiling of Bladder Cancer
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
CN102037355A (zh) 2008-03-04 2011-04-27 里奇诊断学股份有限公司 基于多重生物标记物板块诊断和监测抑郁症
US20110086424A1 (en) 2008-05-06 2011-04-14 Advanced Cell Technology, Inc. Methods for producing enucleated erythroid cells derived from pluripotent stem cells
WO2010147621A1 (en) 2009-06-16 2010-12-23 The Trustees Of Columbia University In The City Of New York Methods for ameliorating adverse effects associated with transfusion of aged red blood cells
CA2769889A1 (en) 2009-08-13 2011-02-17 Basf Se Means and methods for diagnosing thyroid disorders
WO2011091154A2 (en) 2010-01-21 2011-07-28 The Regents Of The University Of California Use of human erythrocytes for prevention and treatment of cancer dissemination and growth
WO2011127056A2 (en) 2010-04-05 2011-10-13 The Uab Research Foundation Biomarkers for assessing exposure to ionizing radiation and absorbed dose
US20150111238A1 (en) 2011-05-31 2015-04-23 Singapore Health Services Pte. Ltd. Method for detecting disease biomarkers
DK2730650T3 (en) 2011-07-06 2017-04-10 Histocell Sl Method of Treating Mesenchymal Stem Cells and Their Use in Treating Oxidative Stress Diseases
GB201116767D0 (en) 2011-09-28 2011-11-09 St George S Hospital Medical School Treatment for mitrochondrial neurogastrointestinal encephalomyopathy
US20150086521A1 (en) 2012-03-21 2015-03-26 Erytech Pharma Medicament for the Treatment of Acute Myeloid Leukemia (AML)
HU230341B1 (hu) 2012-04-20 2016-02-29 Advancell Diagnosztika Kft. A vörösvérsejt-membrán kvantitatív biomarkerei
WO2014011901A2 (en) 2012-07-11 2014-01-16 Sangamo Biosciences, Inc. Methods and compositions for delivery of biologics
CN105228596B (zh) 2013-05-10 2018-08-24 爱瑞德勒股份有限公司 用于制备载有一种或多种制药学感兴趣物质的红细胞的方法和由此得到的红细胞
JP6383920B2 (ja) 2013-09-11 2018-09-05 有限会社ピコデバイス パーキンソン病の判定基準とする方法
KR101845588B1 (ko) 2014-04-07 2018-04-05 한양대학교 산학협력단 적혈구계 세포의 인 비트로 확장
PT3297641T (pt) 2015-05-18 2025-10-09 Hemanext Inc Métodos de armazenamento de sangue total e respetivas composições
HK1258470A1 (zh) 2015-10-07 2019-11-15 善威生物私人有限公司 血液制备和图谱分析
AU2016374643B2 (en) 2015-12-22 2023-12-14 Sangui Bio Pty. Ltd Therapeutic methods using erythrocytes
JP2020502545A (ja) 2016-12-20 2020-01-23 サングイ バイオ ピーティーワイ. エルティーディー プロテアーゼインヒビターを用いる血液プロファイリング

Similar Documents

Publication Publication Date Title
Koelman et al. Cytokines for evaluation of chronic inflammatory status in ageing research: reliability and phenotypic characterisation
Liu et al. Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review
Nogueira et al. Diagnostic biomarkers for active tuberculosis: progress and challenges
Wassall et al. Clinical and technical considerations in the analysis of gingival crevicular fluid
Yetley et al. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary
Wood et al. Validation of cell‐based fluorescence assays: practice guidelines from the ICSH and ICCS–part V–assay performance criteria
US12515222B2 (en) Diagnostic system for hemoglobin analysis
Sheldon et al. C-reactive protein and its cytokine mediators in intensive-care patients
Thyagarajan et al. Analytical and biological variability in biomarker measurement in the Hispanic Community Health Study/Study of Latinos
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
Cray et al. Assessement of serum amyloid A levels in the rehabilitation setting in the Florida manatee (Trichechus manatus latirostris)
WO2007032788A3 (en) Method and apparatus for gel electrophoretic immunoassay
RU2009142935A (ru) Маркеры заболевания
De Graaf et al. Nickel allergy is associated with a broad spectrum cytokine response
RU2019143570A (ru) Диагностика периодонтита на основании hgf и mmp-8 в слюне
JP2018530766A5 (cg-RX-API-DMAC7.html)
Ravindran et al. Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients
Dittadi et al. Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response
Plickert et al. Evaluation of a point‐of‐care test for canine C‐reactive protein
Jenkinson et al. Biochemical analysis of pleural and ascitic fluid: effect of sample timing on interpretation of results
KR101349054B1 (ko) 마이크로 칩을 포함하는 바이오 센서장치
Najjar et al. Application of serum C-reactive protein in comparison with βeta-2-microglobulin in patient with multiple myeloma
Dinesan et al. Evaluation of Salivary 8-Isoprostane in oral lichen planus: Case control study
RU2019143602A (ru) Диагностика гингивита на основании ил-1бета и фактора роста гепатоцитов в слюне
Ríos-Lugo et al. Optimization of buffer solutions to analyze inflammatory cytokines in gingival crevicular fluid by multiplex flow cytometry